Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.
about
Biofilms: survival mechanisms of clinically relevant microorganisms.In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococciBiofilm induced tolerance towards antimicrobial peptidesBiofilm Disrupting Technology for Orthopedic Implants: What's on the Horizon?Lipopeptide biosurfactants from Paenibacillus polymyxa inhibit single and mixed species biofilmsPseudomonas aeruginosa biofilms in cystic fibrosisThe MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQThe MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm toleranceBrlR from Pseudomonas aeruginosa is a c-di-GMP-responsive transcription factorPhysiology of Pseudomonas aeruginosa in biofilms as revealed by transcriptome analysis.Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model.Biofilms and device-associated infectionsEfflux as a glutaraldehyde resistance mechanism in Pseudomonas fluorescens and Pseudomonas aeruginosa biofilmsExperimental and Computational Investigation of Biofilm Formation by Rhodopseudomonas palustris Growth under Two Metabolic Modes.Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilmsMannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm FormationModeling of the Bacillus subtilis Bacterial Biofilm Growing on an Agar SubstrateLinezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.Monitoring microaerobic denitrification of Pseudomonas aeruginosa by online NAD(P)H fluorescence.Antimicrobial-resistant bacteria in the community setting.The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms.Antimicrobial tolerance of Pseudomonas aeruginosa biofilms is activated during an early developmental stage and requires the two-component hybrid SagS.Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner.Comparison of different doses of vancomycin andteicoplanin lock solutions in catheters colonized with Staphylococcus epidermidis: An in vitro, blinded, antibiotic lock study.Biofilms and human health.Engineering serendipity: High-throughput discovery of materials that resist bacterial attachment.P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function.Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.Control of Pseudomonas mastitis on a large dairy farm by using slightly acidic electrolyzed water.Antifouling glycocalyx-mimetic peptoids.A Novel Strategy for Control of Microbial Biofilms through Generation of Biocide at the Biofilm-Surface Interface.In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients.The ABC of biofilm drug tolerance: The MerR-like regulator BrlR is an activator of ABC transport systems, with PA1874-77 contributing to the tolerance by Pseudomonas aeruginosa biofilms to tobramycin.The Yin and Yang of SagS: Distinct Residues in the HmsP Domain of SagS Independently Regulate Biofilm Formation and Biofilm Drug Tolerance.Biofilm parameters influencing biocide efficacy
P2860
Q22299328-1F25B674-E648-4187-A2A4-512D1A3C26B4Q24798259-FA4831A8-A81E-49FC-9249-92D7FC2221B6Q27301462-2689DA54-0951-4228-8E13-CCAEEBAB330EQ28083459-BF43FC65-8979-43DB-A386-9F6F5F3107E0Q28278341-23F21A8E-FCB0-42D1-9FF2-0DCF968D6DEDQ28299966-1EF96DF9-8DEB-47CE-B9FF-6C39DD2E3DD1Q28492677-F28521F7-3D33-448B-9000-6ACA1A2FC952Q28493235-79F8B2B1-7802-4BB2-9E5A-3D8AC3E3243EQ29346796-0BB46762-DA6E-4C2A-9383-9474EB94DD35Q33749041-3CA1B18B-EE39-4CD8-BE1B-195D508C13F4Q33975896-2CAE341E-C06D-4B09-971B-514B9D57299CQ34213700-3F725FE0-42BE-42E8-AC16-533532FACC6BQ35607771-DFF6DD9B-DC4A-46A3-A5D0-9C69004215FAQ35667539-8C972FDF-3221-44D3-A2AA-4AD5E0588BA9Q35820523-075B0BFB-32DE-4175-933E-6E15F61B52B2Q35822955-6A7DEDA7-FCA9-41F5-83FD-61748963B9F4Q36017560-53FC3434-6F80-4371-B3DA-7ABFE59BA7AFQ36047645-5C558B15-A570-4B14-B604-613637811CEDQ36287948-09FCE2A1-7F71-4EA9-A53E-607A46182A91Q36343555-054AB71E-B963-4488-9908-5313DCBE2AF5Q37035909-4F662162-7497-4F63-8594-0A813D28B9EAQ37253144-38C45C63-83C7-4C58-8B49-DE31F0D567A4Q37860818-1B4C54EF-8DD6-404A-ACF2-EACE99210E68Q38472021-A9A35B98-ADBD-4DC9-AA55-65721AA31F57Q38589676-474414D3-1CF3-4CB5-910D-B7AF1C3B497FQ38636376-DCB47B6C-E8EC-4922-AAE8-999484C2AD8CQ39479122-2C57A33E-0F60-4A8A-8EA7-BFB9CFBFA5A9Q39504806-BB3D7C94-F860-463A-AF4D-C3CE30960512Q40075857-CEB6CC95-8771-4E0E-B042-0BBA12E66E9DQ40208189-E6A1BE8F-6B90-4F43-919F-25C6BFD5FE82Q42117834-D6579D50-B44B-48D5-8218-ED20D0CC9504Q43231597-CEE5E533-5A8D-41DD-BEEB-1380A1F38811Q43618599-5782317D-E25C-4FC4-B6B2-30B5C2B31724Q44818432-C3C3010B-6089-493E-9556-8D54CA0B796CQ47406005-BEEEDA5C-833C-421C-AF5D-70967A979AB1Q54977625-E841AAC3-4BE6-4F46-8CA3-B4C6D90F3534Q57225409-3BF6C5F3-651C-4427-98FE-F7804239AE0C
P2860
Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Dynamic interactions of biofil ...... h tobramycin and piperacillin.
@en
Dynamic interactions of biofil ...... h tobramycin and piperacillin.
@nl
type
label
Dynamic interactions of biofil ...... h tobramycin and piperacillin.
@en
Dynamic interactions of biofil ...... h tobramycin and piperacillin.
@nl
prefLabel
Dynamic interactions of biofil ...... h tobramycin and piperacillin.
@en
Dynamic interactions of biofil ...... h tobramycin and piperacillin.
@nl
P2093
P2860
P356
P1476
Dynamic interactions of biofil ...... h tobramycin and piperacillin.
@en
P2093
P2860
P304
P356
10.1128/AAC.36.6.1208
P407
P577
1992-06-01T00:00:00Z